Detall de la convocatòria


Objectiu de la convocatòria
FRAXA is a nonprofit, tax-exempt organization based the US. Solely committed to finding a cure for fragile X, FRAXA has funded more than $25 million in biomedical research, yielding discoveries that are changing the lives of families coping with fragile X. FRAXA is one of the most efficient and effective charities in the world, with management and general expenses under 4 percent and research expenditures at 86 percent.
Característiques principals
  • Supply budget is allowed.
  • Limit of one application per lab group (current grantees are not eligible).
  • Non-transferable (only good for specified postdoc, PI, and institution).
  • Priority is given to research with a translational or preclinical focus on fragile X, which has potential to lead to improved treatment.
  • PIs must demonstrate adequate overall funding to pursue this project. Successful applicants for these grants will likely be working in established labs which have funding for supplies and any required animal handling costs. If the applicant proposes to work with a particular fragile X model (KO mouse, drosophila, neural stem cells, etc.) s/he should demonstrate that this model system has already been established in-house.
  • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: Ext.: 1670
    Marta López: Ext.: 1576
    Convocatòria (URL)
    $45,000 per year: Salary support for one scientist (any degree of BS or higher) working at least ½ time on the project.
    One year. Renewable for a second year of funding (maximum), assuming successful progress and timely submission of a renewal application
    It is recommended (but not absolutely required) that potential applications send a brief Letter of Intent to Michael Tranfaglia, MD ( well in advance of a formal application.